Exploring the Molecular Mechanism of Qing Guang An Granule in Treating Glaucoma Using Network Pharmacology and Molecular Docking

BACKGROUND: Qing Guang An Granule (QGAG), a Chinese patent medicine, has been used clinically to treat glaucoma for more than 20 years. OBJECTIVE: To explore the possible mechanism of treatment of QGAG in glaucoma by using network pharmacology and molecular docking in this study. METHODS: Active com...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Chen, Song, Houpan, Zhou, Yasha, Peng, Jun, Peng, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704137/
https://www.ncbi.nlm.nih.gov/pubmed/33299458
http://dx.doi.org/10.1155/2020/8824150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704137/
https://www.ncbi.nlm.nih.gov/pubmed/33299458
http://dx.doi.org/10.1155/2020/8824150

Ejemplares similares